Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-27 Sale |
2023-12-27 5:37 pm |
POINT Biopharma Global Inc. | PNT | Lubner David Charles Director |
3,600 | $0 | $0 | 0 (Direct) |
View |
| 2023-12-27 Sale |
2023-12-27 5:35 pm |
POINT Biopharma Global Inc. | PNT | MARGOLIN YAEL Director |
1,710 | $0 | $0 | 0 (Direct) |
View |
| 2023-12-18 Sale |
2023-12-20 6:09 pm |
POINT Biopharma Global Inc. | PNT | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Former 10% Owner |
17,161,278 | $12.45 | $213,657,911 | 0 (Direct) |
View |
| 2022-11-29 Purchase |
2022-11-30 7:56 pm |
POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer |
2,160 | $6.64 | $14,342 | 3,616,313 (Direct) |
View |
| 2022-11-23 Purchase |
2022-11-28 4:03 pm |
POINT Biopharma Global Inc. | PNT | Lubner David Charles Director |
3,600 | $6.85 | $24,660 | 3,600 (Direct) |
View |
| 2022-11-25 Purchase |
2022-11-28 4:02 pm |
POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director |
3,660 | $6.815 | $24,943 | 3,660 (Direct) |
View |
| 2022-11-28 Purchase |
2022-11-28 4:01 pm |
POINT Biopharma Global Inc. | PNT | Malik Rajesh Director |
3,700 | $6.66 | $24,642 | 3,700 (Direct) |
View |
| 2022-11-21 Purchase |
2022-11-23 12:43 pm |
POINT Biopharma Global Inc. | PNT | MARGOLIN YAEL Director |
1,710 | $6.56 | $11,218 | 1,710 (Direct) |
View |
| 2022-11-18 Purchase |
2022-11-21 5:54 pm |
POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director |
6,000 | $6.33 | $37,980 | 41,872 (Indirect) |
View |
| 2022-11-17 Purchase |
2022-11-21 5:52 pm |
POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Executive Chairman 10% Owner |
50,000 | $6.224 | $311,199 | 9,227,975 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-26 Equity Swap |
2023-12-27 5:41 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director |
41,872 | $0 | 0 (Indirect) |
View |
| 2023-12-22 Equity Swap |
2023-12-27 5:40 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer |
3,496,313 | $0 | 0 (Direct) |
View |
| 2023-12-22 Equity Swap |
2023-12-27 5:39 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | FLESHNER NEIL E. Chief Medical Officer |
3,006,574 | $0 | 0 (Direct) |
View |
| 2023-12-26 Equity Swap |
2023-12-27 5:37 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director |
21,596 | $0 | 0 (Direct) |
View |
| 2023-12-26 Equity Swap |
2023-12-27 5:37 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | Malik Rajesh Director |
3,700 | $0 | 0 (Direct) |
View |
| 2023-12-26 Equity Swap |
2023-12-27 5:37 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | Lubner David Charles Director |
35,400 | $0 | 0 (Direct) |
View |
| 2023-12-22 Equity Swap |
2023-12-27 5:35 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Executive Chairman |
8,727,975 | $0 | 0 (Indirect) |
View |
| 2023-11-06 Gift |
2023-11-07 6:33 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer |
120,000 | $0 | 3,496,313 (Indirect) |
View |
| 2023-11-03 Gift |
2023-11-07 6:31 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Executive Chairman |
500,000 | $0 | 8,727,975 (Indirect) |
View |
Ownership |
2023-11-06 3:35 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
0 | $0 | 17,161,278 (Direct) |
View |
| 2023-10-31 Gift |
2023-11-02 6:30 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | FLESHNER NEIL E. Chief Medical Officer |
250,000 | $0 | 3,006,574 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-14 6:15 pm |
N/A 2029-06-13 |
POINT Biopharma Global Inc. | PNT | Martell Bridget A Director |
80,503 | $0 | 80,503 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 5:36 pm |
N/A 2029-06-01 |
POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director |
44,749 | $0 | 44,749 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 5:36 pm |
N/A 2029-06-01 |
POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director |
44,749 | $0 | 44,749 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 5:35 pm |
N/A 2029-06-01 |
POINT Biopharma Global Inc. | PNT | MARGOLIN YAEL Director |
44,749 | $0 | 44,749 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 5:35 pm |
N/A 2029-06-01 |
POINT Biopharma Global Inc. | PNT | Malik Rajesh Director |
44,749 | $0 | 44,749 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 5:35 pm |
N/A 2029-06-01 |
POINT Biopharma Global Inc. | PNT | Lubner David Charles Director |
44,749 | $0 | 44,749 (Direct) |
View |
| 2023-03-28 Option Award |
2023-03-30 8:16 pm |
N/A 2029-03-28 |
POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Executive Chairman 10% Owner |
537,322 | $0 | 537,322 (Direct) |
View |
| 2023-03-28 Option Award |
2023-03-30 8:12 pm |
N/A 2029-03-28 |
POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer |
692,643 | $0 | 692,643 (Direct) |
View |
| 2023-03-28 Option Award |
2023-03-30 8:11 pm |
N/A 2029-03-28 |
POINT Biopharma Global Inc. | PNT | KELLY JUSTYNA Chief Operating Officer |
98,358 | $0 | 98,358 (Direct) |
View |
| 2023-03-28 Option Award |
2023-03-30 8:08 pm |
N/A 2029-03-28 |
POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development |
136,055 | $0 | 136,055 (Direct) |
View |
| 2023-03-28 Option Award |
2023-03-30 8:07 pm |
N/A 2029-03-28 |
POINT Biopharma Global Inc. | PNT | FLESHNER NEIL E. Chief Medical Officer |
84,257 | $0 | 84,257 (Direct) |
View |
| 2023-03-28 Option Award |
2023-03-30 8:04 pm |
N/A 2029-03-28 |
POINT Biopharma Global Inc. | PNT | DEMERS WILLIAM L. Chief Financial Officer |
131,355 | $0 | 131,355 (Direct) |
View |
| 2023-03-21 Exercise |
2023-03-23 8:09 pm |
N/A 2026-12-01 |
POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director |
17,936 | $0 | 39,532 (Direct) |
View |
| 2023-03-21 Exercise |
2023-03-23 8:09 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director |
17,936 | $6.97 | 39,532 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:05 pm |
N/A 2028-06-02 |
POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director |
25,614 | $0 | 25,614 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:05 pm |
N/A 2028-06-02 |
POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director |
25,614 | $0 | 25,614 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:04 pm |
N/A 2028-06-02 |
POINT Biopharma Global Inc. | PNT | Lubner David Charles Director |
25,614 | $0 | 25,614 (Direct) |
View |